The AI platform coordinates staffing and beds in real time, a pressure hospitals spend more than $100M a year on…
Multiply Labs says its robotic clusters cut cost per dose by 74% and lift throughput 100-fold over manual biologics production.
Alphabet's AI drug discovery spinout is back in the market less than five months after a $2.1 billion round.
Robinhood Ventures Fund II began trading on the New York Stock Exchange today under the ticker RVII, listing at $25.00…
Adialante is working to make MRI-based cancer screening accessible beyond major hospital centers.
CellType runs agentic drug discovery on simulated human biology, letting AI agents test hypotheses before wet-lab work begins.
Robinhood Ventures Fund II backs healthcare AI startups spanning simulated drug discovery, accessible imaging, and clinical operations.
AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing and life sciences.